Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDerwent London Regulatory News (DLN)

Share Price Information for Derwent London (DLN)

Share Price is delayed by 15 minutes
Get Live Data
2,006.00    60.00 (3.08%)
Bid:
2,000.00
Ask:
2,002.00
Spread: 2.00 (0.10%)
Market Cap: £2.23b
DLN Live PriceLast checked at - London Stock Exchange

Intraday Derwent London Share Chart

Directorate change

22 Jan 2026 09:00

RNS Number : 9492P
Derwent London PLC
22 January 2026
 

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

 

Derwent London plc ("Derwent London" / "the Group")

PAUL WILLIAMS, CHIEF EXECUTIVE, TO RETIRE

Derwent London today announces that Paul Williams has informed the Board of his intention to retire as Chief Executive and Director of the Company.

Paul will remain in his role until his successor is in place at which point he will step down from the Board.

Paul's career at Derwent began shortly after the Company was founded in 1984. He was appointed as an Executive Director in 1998, with responsibility for leasing, asset management and development, and subsequently became Chief Executive in 2019.

A thorough process to appoint a successor, led by the Chairman Mark Breuer, will commence immediately.

Mark Breuer, Chairman, commented: 

"I would like to thank Paul for his dedication and commitment over the last 38 years. During his distinguished career, including his tenure as Chief Executive, he has made an outstanding contribution to Derwent London. With its market leading position, ongoing commitment to capital recycling and significant development pipeline, Derwent London is well placed to create significant value for shareholders."

Paul Williams, Chief Executive, said:

"It has been a huge privilege to have been part of the Derwent story and to have had the opportunity to lead the business over the last six years. I am very proud of what we have achieved, positioning the business with world class assets in prime locations across London, attracting sustained and strong occupational demand. I would like to thank my fellow directors and all the team for their continued hard work and support. I remain fully focused on driving the performance of the business until my successor is in place."

Information equivalent to that required under section 430(2B) of the UK Companies Act 2006 will be made available on the Company's website at the time Paul Williams steps down from the Board and in the Company's 2025 Directors' Remuneration Report.

For further information, please contact:

Derwent London

Tel: +44 (0)20 3478 4217 (Robert Duncan)

Mark Breuer, Chairman

David Lawler, Company Secretary

Robert Duncan, Head of Investor Relations

Brunswick Group

Tel: +44 (0)20 7404 5959

 

 

Simon Sporborg

Nina Coad

Notes to editors

Derwent London plc

Derwent London plc owns a commercial real estate portfolio predominantly in central London valued at £5.2 billion as at 30 June 2025, making it the largest London office-focused real estate investment trust (REIT).

Our experienced team has a long track record of creating value throughout the property cycle by regenerating our buildings via redevelopment or refurbishment, effective asset management and capital recycling. We typically acquire central London properties off-market with low capital values and modest rents in improving locations, most of which are either in the West End or City Borders. We capitalise on the unique qualities of each of our properties - taking a fresh approach to the regeneration of every building with a focus on anticipating tenant requirements and an emphasis on design. Reflecting and supporting our long-term success, the business has a strong balance sheet with modest leverage, a robust income stream and flexible financing.

We are frequently recognised in industry awards for the quality, design and innovation of our projects. Landmark buildings in our 5.3 million sq ft portfolio include 25 Baker Street W1, 1 Soho Place W1, 80 Charlotte Street W1, Brunel Building W2, White Collar Factory EC1, Angel Building EC1 and Tea Building E1.

As part of our commitment to lead the industry in mitigating climate change, Derwent London has committed to becoming a net zero carbon business by 2030, publishing its pathway to achieving this goal in 2020. Our science-based carbon targets have been validated by the Science Based Targets initiative (SBTi). In 2013, we launched a voluntary Community Fund which to date has supported 180 community projects in central London.

The Company is a public limited company, which is listed on the London Stock Exchange and incorporated and domiciled in the UK. The address of its registered office is 25 Savile Row, London, W1S 2ER.

For further information see www.derwentlondon.com or follow us on LinkedIn.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGIGDBIBDDGLD
Date   Source Headline
4th Apr 20124:55 pmRNSDirector/PDMR Shareholding
4th Apr 20124:50 pmRNSDirector/PDMR Shareholding
4th Apr 20124:50 pmRNSDirector/PDMR Shareholding
4th Apr 20124:50 pmRNSDirector/PDMR Shareholding
2nd Apr 20123:30 pmRNSTotal Voting Rights
6th Mar 201210:30 amRNSBlock listing application
1st Mar 20127:01 amRNSGROSVENOR AND DERWENT PARTNERSHIP
1st Mar 20127:00 amRNSDERWENT ANNOUNCES STRONG 2011 RESULTS
23rd Feb 201210:24 amRNSDERWENT LONDON PRE-LETS TO BURBERRY
1st Feb 20127:00 amRNSNotice of Results
1st Dec 201110:00 amRNSBlocklisting Interim Review
1st Dec 201110:00 amRNSTotal Voting Rights
22nd Nov 201110:30 amRNSBlocklisting Interim Review
22nd Nov 201110:30 amRNSBlocklisting Interim Review
17th Nov 20117:00 amRNSInterim Management Statement
14th Nov 201110:00 amRNSNotice of Results
1st Nov 201110:15 amRNSAdditional Listing
5th Oct 201111:30 amRNSScrip Dividend Price Announcement
20th Sep 20119:29 amRNSPlanning permission received
6th Sep 20114:30 pmRNSHolding(s) in Company
24th Aug 20117:00 amRNSStrong Performance from Derwent London
9th Aug 201112:00 pmRNSBondholders meeting
8th Jul 20114:00 pmRNSNotice of Results
6th Jul 20113:00 pmRNSLetting update
4th Jul 201111:00 amRNSTotal Voting Rights
22nd Jun 20114:00 pmRNSDirector/PDMR Shareholding
22nd Jun 20114:00 pmRNSDirector/PDMR Shareholding
22nd Jun 20114:00 pmRNSDirector/PDMR Shareholding
22nd Jun 20114:00 pmRNSDirector/PDMR Shareholding
22nd Jun 20114:00 pmRNSDirector/PDMR Shareholding
13th Jun 201112:00 pmRNSApplication for Listing
31st May 201112:15 pmRNSPublication of Offering Circular
25th May 20113:35 pmRNSScrip Dividend Price Announcement
25th May 201112:40 pmRNSDirectorate Change
24th May 20114:15 pmRNSAdditional Listing
23rd May 20114:00 pmRNSResult of AGM
20th May 20115:00 pmRNSBlocklisting Interim Review
20th May 20115:00 pmRNSBlocklisting Interim Review
17th May 20113:45 pmRNSConvertible bond offering
17th May 20117:02 amRNSCovent Garden Disposal for £68 Million
17th May 20117:01 amRNSConvertible Bond Offering
17th May 20117:00 amRNSInterim Management Statement
17th May 20117:00 amRNSAcquisition of five properties in Covent Garden
10th May 20113:30 pmRNSAnnual Information Update
19th Apr 201110:30 amRNSAnnual Report & Accounts and Notice of AGM
10th Mar 20117:01 amRNSAcquisition
10th Mar 20117:00 amRNSAnnual Financial Report
10th Feb 20113:47 pmRNSNotice of Results
22nd Nov 201010:00 amRNSBlocklisting Interim Review
22nd Nov 201010:00 amRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.